On the other hand, the presence of NAFLD as comorbidity seems to be associated with a worse metabolic profile, the need for higher insulin doses and the severity of diabetic microvascular complications in T2DM patients. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.